Citigroup’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,319
Closed -$6.39K 6372
2025
Q3
$6.39K Sell
4,319
-19,605
-82% -$29.9K ﹤0.01% 5161
2025
Q2
$27.8K Sell
23,924
-21,619
-47% -$30.5K ﹤0.01% 4998
2025
Q1
$61.5K Sell
45,543
-7,038
-13% -$42.7K ﹤0.01% 4822
2024
Q4
$692K Buy
52,581
+3,041
+6% +$41.5K ﹤0.01% 3607
2024
Q3
$555K Buy
49,540
+31,991
+182% +$400K ﹤0.01% 3665
2024
Q2
$189K Sell
17,549
-195,756
-92% -$2.52M ﹤0.01% 3904
2024
Q1
$3.18M Buy
213,305
+141,830
+198% +$2.34M ﹤0.01% 2047
2023
Q4
$1.29M Buy
71,475
+57,949
+428% +$881K ﹤0.01% 2618
2023
Q3
$235K Sell
13,526
-10,758
-44% -$187K ﹤0.01% 3580
2023
Q2
$440K Sell
24,284
-509
-2% -$12K ﹤0.01% 3458
2023
Q1
$659K Sell
24,793
-702
-3% -$20K ﹤0.01% 2899
2022
Q4
$493K Buy
25,495
+19,843
+351% +$415K ﹤0.01% 3186
2022
Q3
$118K Buy
5,652
+4,481
+383% +$85.7K ﹤0.01% 4013
2022
Q2
$9K Sell
1,171
-891
-43% -$5.71K ﹤0.01% 5407
2022
Q1
$14K Sell
2,062
-5,723
-74% -$58.4K ﹤0.01% 5362
2021
Q4
$105K Buy
7,785
+2,858
+58% +$45.4K ﹤0.01% 4709
2021
Q3
$83K Buy
4,927
+708
+17% +$15K ﹤0.01% 4484
2021
Q2
$123K Buy
4,219
+1,143
+37% +$35.6K ﹤0.01% 4438
2021
Q1
$121K Sell
3,076
-429
-12% -$13.9K ﹤0.01% 4273
2020
Q4
$80K Buy
3,505
+3,005
+601% +$75.3K ﹤0.01% 5715
2020
Q3
$11K Buy
+500
New +$12.5K ﹤0.01% 6569

Other funds holding PLRX